SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on September 12, 2023, reporting an event that occurred on September 6, 2023. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market under the symbol "BSGM".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
The Company received a notice from Nasdaq indicating a failure to meet the minimum bid price requirement of $1.00 per share. This deficiency was based on the closing bid price over the 30 consecutive business days from July 25, 2023, to September 5, 2023. There is no immediate impact on the listing status; the stock continues to trade on The Nasdaq Capital Market.
Outlook, Risks, and Contingencies
- Compliance Period: The Company has been granted an initial 180-day compliance period ending March 4, 2024, to regain compliance.
- Remediation Requirement: To cure the deficiency, the common stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days during the compliance period.
- Delisting Risk: If the Company fails to regain compliance by the end of the period, it may be subject to delisting unless it qualifies for an additional cure period.
- Secondary Cure Option: To qualify for an additional 180 days, the Company must meet all other initial listing standards (excluding bid price) and may need to effect a reverse stock split.
Investor Verification Checklist
- Verify the current closing bid price of BSGM to assess progress toward the $1.00 threshold.
- Monitor the Company's stock price for ten consecutive days of compliance above $1.00.
- Review future filings for announcements regarding a potential reverse stock split if the initial cure period is insufficient.
- Confirm the Company's status regarding other Nasdaq listing requirements (e.g., market value of publicly held shares) in case a second compliance period is needed.